Provided by Tiger Trade Technology Pte. Ltd.

Emergent BioSolutions

11.77
+0.35963.15%
Volume:289.60K
Turnover:3.40M
Market Cap:618.14M
PE:8.71
High:11.97
Open:11.38
Low:11.38
Close:11.41
52wk High:13.41
52wk Low:4.02
Shares:52.52M
Float Shares:51.26M
Volume Ratio:0.54
T/O Rate:0.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.35
EPS(LYR):-3.5962
ROE:13.92%
ROA:5.27%
PB:1.06
PE(LYR):-3.27

Loading ...

Aptevo Therapeutics Reports Q2 2025 Net Loss of $6.2M, EPS at $8.40, Compared to $5.9M Loss and $1,236.96 EPS in Q2 2024

Reuters
·
Aug 11

Aptevo Therapeutics Inc expected to post a loss of $83.20 a share - Earnings Preview

Reuters
·
Aug 08

Emergent BioSolutions Files for Mixed Shelf Offering of Upto $250 Mln - Filing

THOMSON REUTERS
·
Aug 08

Emergent BioSolutions Q2 Adj. EPS $0.16 Beats $(0.72) Estimate, Sales $140.90M Beat $105.00M Estimate

Benzinga
·
Aug 07

Emergent BioSolutions Inc Outlook Q3 Total Revenues $180 Mln - $210 Mln

THOMSON REUTERS
·
Aug 07

Emergent BioSolutions Inc Outlook FY Total Revenues $765 Mln - $835 Mln

THOMSON REUTERS
·
Aug 07

Emergent BioSolutions Q2 Gross Margin 36%

THOMSON REUTERS
·
Aug 07

Emergent BioSolutions Q2 Adjusted Gross Margin 49%

THOMSON REUTERS
·
Aug 07

Emergent BioSolutions Reports Second Quarter 2025 Financial Results

GlobeNewswire
·
Aug 07

Emergent BioSolutions Inc expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
Aug 05

Aptevo Therapeutics Inc expected to post a loss of $83.20 a share - Earnings Preview

Reuters
·
Aug 04

Emergent BioSolutions Drops Amid Volume Spike, Last Down 5.8%

THOMSON REUTERS
·
Jul 29

New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential Antiviral Treatment for Mpox

GlobeNewswire
·
Jul 28

Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives

GlobeNewswire
·
Jul 28

Aptevo Therapeutics Inc. Conducted Annual Stockholder Meeting

Reuters
·
Jul 25

Emergent BioSolutions Inc. to Announce Second Quarter 2025 Financial Results

Reuters
·
Jul 15

Aptevo Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Dirk Huebner, SVP and CMO

Reuters
·
Jul 10

Emergent BioSolutions Shares Rise Over 6% After HHS Contract Modification

Dow Jones
·
Jul 09

Emergent BioSolutions Secures $51.9 Million Contract for Smallpox Treatment with U.S. Government

Reuters
·
Jul 09

Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate

GlobeNewswire
·
Jul 03